Loading institutional data...
Loading institutional data...
Held by 354 of 2,417 reporting institutions (97th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ranked against 17 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TMO | $262.2B | 40.0× | 33.5× | 5.9× | 3.9% | — | 15.0% | 12.6% | 7.0% | 3.7× | 953 |
| KLAC | $218.5B | 45.8× | — | 16.1× | 11.7% | 61.3% | 35.6% | 76.1% | 39.5% | — | 751 |
| DHR | $166.6B | 46.9× | 34.0× | 6.8× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 700 |
| TT | $94.9B | 33.2× | 23.4× | 4.5× | 7.5% | — | 13.7% | 34.0% | 22.1% | 0.7× | 570 |
| AME | $57.7B | 39.3× | 29.0× | 7.8× | 6.6% | 36.0% | 20.0% | 13.9% | 11.5% | 0.9× | 337 |
| KEYS | $56.2B | 67.2× | 56.4× | 10.4× | 8.0% | 62.1% | 15.8% | 14.5% | 10.1% | 0.7× | 354 |
| A | $51.1B | 39.6× | 29.8× | 7.3× | 6.7% | 52.4% | 18.8% | 19.3% | 12.9% | 0.9× | 357 |
| ROK | $50.1B | 58.9× | 26.1× | 6.0× | 0.9% | 48.1% | 10.4% | 23.8% | 12.6% | 1.4× | 464 |
| WAT | $47.1B | 44.6× | 53.3× | 14.9× | 7.0% | 59.3% | 20.3% | 25.1% | 18.3% | 0.4× | 360 |
| COHR | $46.7B | 57.6× | — | 6.6× | 22.5% | 37.5% | 11.3% | 7.4% | 5.7% | — | 334 |
| TER | $46.3B | 85.4× | 59.4× | 14.5× | 13.1% | 58.2% | 17.4% | 19.8% | 18.5% | -0.1× | 385 |
| ROP | $44.5B | 31.7× | 17.1× | 5.6× | 12.3% | 69.2% | 19.4% | 7.7% | 5.3% | 2.9× | 303 |
| ILMN | $43.8B | 53.2× | 40.7× | 10.1× | -0.7% | 66.1% | 19.6% | 31.2% | 31.2% | 0.0× | 308 |
| MTD | $34.4B | 40.9× | 33.8× | 8.6× | 4.0% | 59.4% | 21.6% | — | 40.8% | 2.0× | 195 |
| VLTO | $25.4B | 27.7× | 19.2× | 4.6× | 6.0% | 59.9% | 17.1% | 30.3% | 16.3% | 0.5× | 282 |
| FTV | $19.6B | 38.1× | 19.4× | 4.7× | 1.9% | 63.5% | 13.9% | 9.0% | 6.0% | 2.4× | 203 |
| RVTY | $18.5B | 80.1× | 27.3× | 6.5× | 3.7% | — | 8.4% | 3.3% | 2.3% | 3.0× | 133 |
| TRMB | $15.2B | 37.1× | 20.7× | 4.3× | -2.6% | 69.1% | 11.8% | 7.3% | 5.9% | 1.4× | 172 |
Peers = companies sharing KEYS's sector (Industrial Instruments For Measurement, Display, and Control) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $307.20 today, the market must believe free cash flow compounds 23.2%/yr for a decade (off $1.13B on the 3-yr avg basis).
On the basis ($985.3M) the requirement is 25.2%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 23.2% is more optimistic than its 9-yr track record.
Default is 11.8% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.17B shares (market data) · net debt $661.0M
mean 23.0% · volatility σ 44% · implied rate exceeded in 5/9 yrs
Central path = implied 23.2%/yr growth; shaded band = ±1σ (44%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $375.0M buybacks = $375.0M returned on $1.28B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 10%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.8% on $2.53B of debt.
Cash of $1.87B fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.38B 100.0% | $4.98B 100.0% | $5.46B 100.0% | $5.42B 100.0% | $4.94B 100.0% | $4.22B 100.0% | $4.30B 100.0% | $3.88B 100.0% | $3.19B 100.0% | $2.92B 100.0% |
| Cost of Revenue | $2.04B 37.9% | $1.85B 37.1% | $1.93B 35.4% | $1.97B 36.3% | $1.87B 37.9% | $1.69B 40.0% | $1.77B 41.1% | $1.77B 45.6% | $1.49B 46.6% | $1.29B 44.3% |
| Cost of Products | — | — | — | — | — | — | — | — | $1.21B 37.8% | $1.04B 35.7% |
| Cost of Services | — | — | — | — | — | — | — | — | $281.0M 8.8% | $252.0M 8.6% |
| Research & Development | $1.01B 18.7% | $919.0M 18.5% | $882.0M 16.1% | $841.0M 15.5% | $811.0M 16.4% | $715.0M 16.9% | $688.0M 16.0% | $624.0M 16.1% | $507.0M 15.9% | $434.0M 14.9% |
| Selling, General & Admin | $1.47B 27.4% | $1.40B 28.0% | $1.31B 23.9% | $1.28B 23.7% | $1.20B 24.2% | $1.10B 26.0% | $1.16B 26.8% | $1.21B 31.1% | $1.06B 33.2% | $832.0M 28.5% |
| Total Operating Expenses | $4.50B 83.7% | $4.15B 83.3% | $4.11B 75.1% | $4.09B 75.4% | $3.86B 78.1% | $3.46B 81.9% | $3.59B 83.5% | $4.27B 110.2% | $3.04B 95.4% | $2.54B 87.1% |
| Operating Income | $876.0M 16.3% | $833.0M 16.7% | $1.36B 24.9% | $1.33B 24.6% | $1.08B 21.9% | $765.0M 18.1% | $711.0M 16.5% | -$394.0M -10.2% | $148.0M 4.6% | $375.0M 12.9% |
| Interest Expense | $96.0M 1.8% | $84.0M 1.7% | $78.0M 1.4% | $79.0M 1.5% | $79.0M 1.6% | $78.0M 1.8% | $80.0M 1.9% | $83.0M 2.1% | $80.0M 2.5% | $47.0M 1.6% |
| Interest & Investment Income | $102.0M 1.9% | $81.0M 1.6% | $102.0M 1.9% | $16.0M 0.3% | $3.0M 0.1% | $11.0M 0.3% | $23.0M 0.5% | $12.0M 0.3% | $7.0M 0.2% | $3.0M 0.1% |
| Other Income (Expense), net | $200.0M 3.7% | $35.0M 0.7% | -$25.0M -0.5% | $14.0M 0.3% | $6.0M 0.1% | $63.0M 1.5% | $61.0M 1.4% | $54.0M 1.4% | $104.0M 3.3% | $35.0M 1.2% |
| Pretax Income | $1.08B 20.1% | $865.0M 17.4% | $1.36B 24.8% | $1.28B 23.7% | $1.01B 20.4% | $761.0M 18.0% | $715.0M 16.6% | $735.0M 19.0% | $598.0M 18.8% | $515.0M 17.6% |
| Income Tax Expense | $213.0M 4.0% | $251.0M 5.0% | $300.0M 5.5% | $161.0M 3.0% | $116.0M 2.3% | $134.0M 3.2% | $94.0M 2.2% | -$576.0M -14.9% | $77.0M 2.4% | $31.0M 1.1% |
| Net Income | $850.0M 15.8% | $614.0M 12.3% | $1.06B 19.3% | $1.12B 20.7% | $894.0M 18.1% | $627.0M 14.9% | $621.0M 14.4% | $165.0M 4.3% | $102.0M 3.2% | $335.0M 11.5% |
| Per Share | ||||||||||
| EPS (Basic) | $4.93 | $3.53 | $5.95 | $6.23 | $4.84 | $3.35 | $3.31 | $0.88 | $0.57 | $1.97 |
| EPS (Diluted) | $4.91 | $3.51 | $5.91 | $6.18 | $4.78 | $3.31 | $3.25 | $0.86 | $0.56 | $1.95 |
| Weighted Avg Shares (Basic) | 172.0M | 174.0M | 178.0M | 180.0M | 185.0M | 187.0M | 188.0M | 187.0M | 180.0M | 170.0M |
| Weighted Avg Shares (Diluted) | 173.0M | 175.0M | 179.0M | 182.0M | 187.0M | 189.0M | 191.0M | 191.0M | 182.0M | 172.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 11-yr range · 96th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 11-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 14% against ROIC 10% — 4% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 15.5% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 45.6 | 41.1 | 40.0 | 37.9 | 36.3 | 35.4 | 37.1 | 37.9 |
| R&D | 16.1 | 16.0 | 16.9 | 16.4 | 15.5 | 16.1 | 18.5 | 18.7 |
| SG&A | 31.1 | 26.8 | 26.0 | 24.2 | 23.7 | 23.9 | 28.0 | 27.4 |
| Operating Income | -10.2 | 16.5 | 18.1 | 21.9 | 24.6 | 24.9 | 16.7 | 16.3 |
| Income Tax | -14.9 | 2.2 | 3.2 | 2.3 | 3.0 | 5.5 | 5.0 | 4.0 |
| Net Income | 4.3 | 14.4 | 14.9 | 18.1 | 20.7 | 19.3 | 12.3 | 15.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on KEYS: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -1.75pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 16.6% | 11.8% (today's — no rate published for this year) | 4.8pts |
| FY2020 | 16.2% | 11.8% (today's — no rate published for this year) | 4.4pts |
| FY2021 | 21.4% | 5.2% | 16.2pts |
| FY2022 | 24.0% | 8.9% | 15.1pts |
| FY2023 | 24.0% | 10.2% | 13.9pts |
| FY2024 | 11.7% | 11.0% | 0.7pts |
| FY2025 | 9.7% | 10.8% | -1.1pts |
| Now | 10.1% | 11.8% | -1.7pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 55.7% | 13.9% | 11.5% |
| FY2017 | 53.4% | 4.6% | 3.2% |
| FY2018 | 54.4% | -10.2% | 4.3% |
| FY2019 | 58.9% | 16.5% | 14.4% |
| FY2020 | 60.0% | 18.1% | 14.9% |
| FY2021 | 62.1% | 21.9% | 18.1% |
| FY2022 | 63.7% | 24.6% | 20.7% |
| FY2023 | 64.6% | 24.9% | 19.3% |
| FY2024 | 62.9% | 16.7% | 12.3% |
| FY2025 | 62.1% | 16.3% | 15.8% |
Leverage and buybacks account for 4 points of the 14% return on equity in FY2025. The business earns 10% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$3.5B of goodwill — 52% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 20.91% against 10.05% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.25x of reported profit into cash — adequate, without much margin.
Reported free cash flow is $1.28B; after share-based compensation it is $1.12B. The difference is a real cost that the cash flow statement adds back.
Covers interest 6.4x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 9.12x |
| 5% | 8.67x |
| 10% | 8.21x |
| 15% | 7.76x |
| 20% | 7.30x |
| 25% | 6.84x |
| 30% | 6.39x |
| 35% | 5.93x |
| 40% | 5.47x |
| 45% | 5.02x |
| 50% | 4.56x |
| 55% | 4.11x |
| 60% | 3.65x |
Balance sheet at 2025-10-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $329.84, free cash flow must compound 24.28%/yr for 10 years. It has done 6.5%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 2.4% | 24.3% |
| FY2021 | 27.7% | 24.3% |
| FY2022 | −16.5% | 24.3% |
| FY2023 | 26.3% | 24.3% |
| FY2024 | −25.8% | 24.3% |
| FY2025 | 42.7% | 24.3% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
The implied rate has been matched or beaten in 3 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $850M | $850M |
| Share-based comp | $162M | $1.01B |
| Other non-cash & working capital | $397M | $1.41B |
| Operating cash flow | $1.41B | $1.41B |
| Capex | −$128M | $1.28B |
| Free cash flow | $1.28B | $1.28B |
| FCF after SBC | $1.12B | $1.12B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -1.9% | -9.3% | -7.4 points |
| FY2021 | 17.1% | 21.3% | 4.2 points |
| FY2022 | 9.7% | 23.1% | 13.4 points |
| FY2023 | 0.8% | -0.6% | -1.4 points |
| FY2024 | -8.9% | -4.8% | 4.1 points |
| FY2025 | 8.0% | 9.6% | 1.6 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 56.7 days | 145.5 days | 52.2 days | 149.9 days |
| FY2020 | 52.4 days | 163.7 days | 48.4 days | 167.7 days |
| FY2021 | 54.3 days | 151.5 days | 56 days | 149.8 days |
| FY2022 | 60.9 days | 159 days | 64.5 days | 155.4 days |
| FY2023 | 60.1 days | 186.1 days | 54 days | 192.2 days |
| FY2024 | 62.8 days | 202.1 days | 61.9 days | 203 days |
| FY2025 | 63.8 days | 188.1 days | 63.6 days | 188.2 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -5.7 percent |
| FY2020 | -5.4 percent |
| FY2021 | -5.5 percent |
| FY2022 | -0.3 percent |
| FY2023 | -4.0 percent |
| FY2024 | -4.7 percent |
| FY2025 | -5.0 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Juskie Jo Ann SVP | Tax withholding | 1,375 | $331.21 | $455k |
| 2026-10-16 | Li Jeffrey K SVP and Secretary | Tax withholding | 1,479 | $331.21 | $490k |
| 2026-09-30 | Dhanasekaran Satish President and CEO | Open-market sale | 3,000 | $364.13 | $1.1m |
| 2026-09-23 | Poole Lisa M. VP and Controller | Open-market sale |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 200 |
| $348.01 |
| $70k |
| 2026-09-21 | Dougherty Neil EVP and CFO | Open-market sale | 2,000 | $340.79 | $682k |
| 2026-09-04 | Estrada Ingrid A SVP | Open-market sale | 2,000 | $326.10 | $652k |
| 2026-08-26 | Reese Scott Director | Grant | 435 | $0.00 | $0 |
| 2026-08-21 | Nye Jean Mcclung Director | Open-market sale | 3,000 | $319.22 | $958k |
| 2026-08-20 | Estrada Ingrid A SVP | 10b5-1 plan sale | 2,000 | $314.66 | $629k |
| 2026-08-01 | Poole Lisa M. VP and Controller | Tax withholding | 32 | $319.08 | $10k |
| 2026-07-06 | Allouche Arnaud SVP | Grant | 1,474 | $0.00 | $0 |
| 2026-06-30 | Estrada Ingrid A SVP | 10b5-1 plan sale | 2,000 | $340.87 | $682k |
| 2026-06-25 | Dhanasekaran Satish President and CEO | 10b5-1 plan sale | 507 | $361.32 | $183k |
| 2026-06-02 | Cullen James Director | Open-market sale | 3,000 | $346.58 | $1.0m |
| 2026-05-26 | Juskie Jo Ann SVP | Tax withholding | 136 | $355.74 | $48k |
| 2026-05-18 | Dhanasekaran Satish President and CEO | Tax withholding | 500 | $340.48 | $170k |
| 2026-03-30 | Hamada Richard P Director | Open-market sale | 870 | $275.78 | $240k |
| 2026-03-24 | Li Jeffrey K SVP and Secretary | Open-market sale | 2,000 | $297.19 | $594k |
| 2026-03-24 | Dhanasekaran Satish President and CEO | Open-market sale | 1,667 | $300.00 | $500k |
| 2026-03-24 | Dougherty Neil EVP and CFO | Open-market sale | 2,000 | $298.37 | $597k |
| 2026-03-20 | Holthaus Michelle Johnston Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Stephens Kevin A Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Olsen Joanne Beth Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Nersesian Ronald S. Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Jensen Keith Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Dockendorff Charles J Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Hamada Richard P Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Cullen James Director | Grant | 870 | $0.00 | $0 |
| 2026-03-20 | Nye Jean Mcclung Director | Grant | 870 | $0.00 | $0 |
| 2026-03-19 | Dhanasekaran Satish President and CEO | Open-market sale | 1,667 | $290.00 | $483k |
| 2026-03-17 | Nersesian Ronald S. Director | 10b5-1 plan sale | 30,000 | $285.96 | $8.6m |
| 2026-02-27 | Juskie Jo Ann SVP | Open-market sale | 1,000 | $304.42 | $304k |
| 2026-02-20 | Estrada Ingrid A SVP | 10b5-1 plan sale | 2,000 | $237.68 | $475k |
| 2026-01-12 | Nersesian Ronald S. Director | Tax withholding | 5,012 | $206.35 | $1.0m |
| 2025-12-30 | 2 co-filers SVP | Open-market sale | 889 | $206.66 | $184k |
| 2025-12-30 | Dougherty Neil EVP and CFO | Gift | 561 | $0.00 | $0 |
| 2025-12-30 | 2 co-filers SVP | Gift | 500 | $0.00 | $0 |
| 2025-12-22 | Dougherty Neil EVP and CFO | Open-market sale2d late | 1,000 | $203.72 | $204k |
| 2025-12-11 | Juskie Jo Ann SVP | Tax withholding | 203 | $201.40 | $41k |
| 2025-12-11 | Yoon Sung SVP | Tax withholding | 152 | $201.40 | $31k |